Alkermes (ALKS) Gross Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 631.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -673.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -675.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -838.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 33.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -344.00 |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 455.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455.00 |
| Dec 31, 2025 | 568.00 |
| Sep 30, 2025 | 156,894.00 |
| Jun 30, 2025 | 181,109.00 |
| Mar 31, 2025 | 375.00 |
| Dec 31, 2024 | 208.00 |
| Sep 30, 2024 | 16.00 |
| Jun 30, 2024 | 209.00 |
| Mar 31, 2024 | -42.00 |
| Dec 31, 2023 | -325.00 |
| Sep 30, 2023 | 13.00 |
| Jun 30, 2023 | 796.00 |
| Mar 31, 2023 | -105.00 |
| Dec 31, 2022 | 91,194.00 |
| Sep 30, 2022 | -156,545.00 |
| Jun 30, 2022 | -180,723.00 |
| Mar 31, 2022 | 53.00 |
| Dec 31, 2021 | 325,794.00 |
| Sep 30, 2021 | -100.00 |
| Jun 30, 2021 | -324.00 |